Mairs & Power, an investment advisor, released the third-quarter 2025 investor letter for the “Mairs & Power Balanced Fund.” ...

UnitedHealth Group is far from the perfect stock, but it is an appealing buy because it can learn from its errors and ...

Shares of the healthcare giant are still down more than 30% year to date, after plunging as much as 53% at one point. Should ...

One year after UnitedHealthcare's CEO was shot and killed, the crisis in U.S. health care is intensifying — even for the ...

If Stephen A. Smith is not planning a run for president anytime soon, he’s doing his best impersonation of a buzzworthy politician in the meantime. “I’m not ruling anything out, but I’m not thinking ...

In “Doctor Dolittle’s Delusion,” he argued that language is a biological system unique to humans, despite the widespread belief that it extended to other animals. By Michael S. Rosenwald The linguist ...

UnitedHealth Group announced on Tuesday that Scott Gottlieb, a former commissioner of the FDA, is joining its board of directors effective immediately, marking CEO Stephen Hemsley's latest effort to ...

It's seen as the latest effort by CEO Stephen Hemsley — who was appointed in May — to turn around the insurance giant, which has struggled since the December 2024 slaying of UnitedHealthcare CEO Brian ...

Cullen Capital Management, LLC, operating under the name Schafer Cullen Capital Management, Inc. (SCCM), has released its “SCCM Value Equity Strategy” third-quarter investor letter. A copy of the ...

Former U.S. Food and Drug Administration Commissioner Scott Gottlieb, MD, has been named to UnitedHealth Group’s board of directors. Dr. Gottlieb served as FDA commissioner from 2017 to 2019, “where ...

Nov 18 (Reuters) - UnitedHealth Group (UNH.N), opens new tab said on Tuesday it had named former U.S. Food and Drug Administration commissioner Scott Gottlieb to its board, effective immediately.

(Reuters) -UnitedHealth Group said on Tuesday it had named former U.S. Food and Drug Administration commissioner Scott Gottlieb to its board, effective immediately. Gottlieb, who had served as the FDA ...